Anders Månsson is a businessperson who has been at the helm of 6 different companies. Currently, he holds the position of Chairman of EQL Pharma AB, Chairman of CanImGuide Therapeutics AB and Chief Executive Officer & Director at Anders Månsson Business Development AB.
He is also on the board of Amniotics AB (former Chief Executive Officer) and Chief Executive & Business Officer at RhoVac AB.
In the past he was Vice President & Head-Global Business Development at LEO Pharma A.
He received an undergraduate degree from the University of Lund and an MBA from Business School Lausanne.